| abstract |
It provides a method of administering pypenidone to patients with abnormal liver function biomarker levels by the use of pypenidone. According to this method, the patient is dosed with less than the entire amount of the treatment, for a predetermined period of time, and then the patient is treated with the full amount of the treatment. The method also includes a method of administering the entire amount of treatment without lowering the use amount of pypnidone and a method of lowering the use amount of pypenidone throughout the treatment. |